SixPeaks Bio AG

About SixPeaks Bio AG

SixPeaks Bio is focused on providing healthy weight loss and metabolic fitness solutions by targeting muscle preservation and expansion. They aim to develop therapeutic companions to GLP-1 receptor agonists (GLP1 RAs) to protect lean tissue mass as a core component of future weight management solutions.

Products & Services

Lead Program (ActR2A/B):A potential best-in-class program targeting ActR2A/B, developed by an experienced team with deep knowledge in ActR2A/B biology and monoclonal antibody (mAb) engineering.

Next Generation Molecules:Development of precision medicine conjugates in cardiometabolism, leveraging in-house expertise in conjugation and bispecific mAb technologies.

Antibodies and Conjugates Platform:A state-of-the-art antibody engineering and conjugation platform with world-class capabilities.

Specialties

Muscle preservation for weight loss ActR2A/B biology Monoclonal antibody (mAb) engineering Precision medicine conjugates Cardiometabolism Antibody engineering Conjugation platform

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 110000000 MR: - FA: $110 million FAN: 110000000	D: 2024-05-22 FD: 2024-05-22	2 investors

Series A Latest

2024-05-22

$110.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Konrad Bleicher

SVP Therapeutic Modalities

P

Philip Just Larsen

Chief Executive Officer

E

Estelle Marrer-Berger

SVP Non-Clinical & Translational Development

C

Cornelia Maurer

Director Finance

A

Andreas Popp

SVP CMC

C

Cora Scholten

Director Alliance Management

View 13 more team members with Pro

Unlock Full Team Directory

Recent News

SixPeaks Bio AG Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised